Company Overview
Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and internationally. It operates through three segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers surfactants that are used in consumer and industrial cleaning and disinfection products, including detergents for washing clothes, dishes, carpets, and floors and walls, as well as shampoos and body washes; and other applications, such as fabric softeners, germicidal quaternary compounds, disinfectants, lubricating ingredients; emulsifiers for spreading agricultural products; and industrial applications comprising latex systems, plastics, and composites. The Polymers segment provides polyurethane polyols that are used in the manufacture of rigid foam for thermal insulation in the construction industry, as well as a base raw material for coatings, adhesives, sealants, and elastomers (CASE); polyester resins used in coating applications; specialty polyols, such as CASE and powdered polyester resins; and phthalic anhydride that is used in unsaturated polyester resins, alkyd resins, and plasticizers for applications in construction materials, as well as components of automotive, boating, and other consumer products. The Specialty Products segment offers flavors, emulsifiers, and solubilizers for use in food, flavoring, nutritional supplement, and pharmaceutical applications. Stepan Company was founded in 1932 and is headquartered in Northbrook, Illinois.
Why Investors Should Care
Offers a dividend yield of 2.78%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $2.33B (+7.0% YoY); net profit $46.90M.
- Trailing 12 Months Year-on-year growth — revenue +1.9%, earnings -6.9%.
- 5-Year Trend Long-term compounding — revenue CAGR 3.8%, profit CAGR -1.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 3.84% |
| 1 Year: | 1.90% |
Compounded Profit Growth
| 5 Years: | -1.83% |
| 1 Year: | -6.90% |
Stock Price Performance
| 1 Year: | +3.79% |
| 6 Months: | +14.66% |
| 3 Months: | +14.10% |
| 1 Month: | +7.64% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)69.82 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Attractive dividend yield of 2.78%.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Earnings shrank at -1.8% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | SCL Stepan Company R2K | 58.64 | -94.58 | $1.33B | 2.78% | 4.64% | -1.19% | 3.84% | -1.83% |
| 2 | LIN Linde plc NDXSPX | 514.15 | 34.05 | $237.72B | 1.22% | 12.46% | 18.23% | 13.90% | 18.47% |
| 3 | NEM Newmont Corporation SPX | 95.21 | 12.35 | $101.64B | 1.10% | - | 25.83% | 6.53% | 20.15% |
| 4 | FCX Freeport-McMoRan Inc. SPX | 60.97 | 32.26 | $87.65B | 0.97% | 12.50% | 15.63% | 1.35% | -1.26% |
| 5 | SHW The Sherwin-Williams Company SPX | 332.29 | 31.92 | $81.95B | 0.97% | 21.93% | 60.72% | 6.18% | 8.26% |
| 6 | ECL Ecolab Inc. SPX | 270.25 | 36.57 | $76.06B | 1.07% | 14.29% | 22.43% | 6.17% | 9.18% |
| 7 | CRH CRH plc SPX | 103.96 | 19.04 | $69.47B | 1.52% | 10.97% | 15.81% | 6.41% | 9.30% |
| 8 | APD Air Products and Chemicals, Inc. SPX | 293.69 | 30.98 | $65.40B | 2.40% | -0.62% | 12.35% | -1.77% | -39.16% |
| 9 | CTVA Corteva, Inc. SPX | 84.45 | 46.15 | $56.48B | 0.84% | - | 5.14% | 2.86% | 9.94% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | 468.27M | 495.10M | 487.81M | 473.82M | 499.33M | 519.87M | 508.00M | 466.66M | 489.17M | 473.00M | 451.58M | 444.99M | 449.99M | 460.55M | 464.48M | 537.74M | 595.51M | 602.69M | 675.28M | 751.63M | 719.18M | 651.44M | 579.98M | 562.23M | 551.42M | 556.40M | 546.84M | 593.25M | 594.69M | 590.28M | 604.51M |
| Gross Profit | 49.85M | 76.44M | 79.51M | 77.60M | 74.69M | 93.50M | 92.93M | 83.39M | 68.72M | 92.12M | 89.99M | 75.58M | 80.84M | 91.20M | 89.98M | 83.58M | 74.59M | 84.61M | 92.96M | 77.40M | 84.74M | 79.27M | 98.50M | 97.06M | 108.98M | 111.68M | 91.90M | 109.22M | 131.61M | 118.48M | 73.56M | 66.40M | 71.24M | 70.28M | 69.55M | 75.69M | 75.46M | 71.89M | 71.02M | 64.85M |
| Operating Income | 9.00M | 35.18M | 28.59M | 38.79M | 20.22M | 44.61M | 42.92M | 28.74M | 9.93M | 46.23M | 39.13M | 30.43M | 31.40M | 41.28M | 45.39M | 27.14M | 35.45M | 29.74M | 41.06M | 27.97M | 28.49M | 40.00M | 44.62M | 42.40M | 53.91M | 56.66M | 40.21M | 63.35M | 77.64M | 54.66M | 21.06M | 17.81M | 19.52M | 20.17M | 18.67M | 23.95M | 28.29M | 17.96M | 21.79M | -49.62M |
| Net Income | 6.24M | 21.27M | 16.91M | 24.91M | 12.87M | 27.92M | 28.50M | 21.36M | 8.42M | 31.91M | 27.88M | 21.90M | 9.88M | 31.95M | 33.45M | 21.75M | 23.96M | 24.98M | 30.22M | 25.89M | 22.04M | 27.55M | 35.71M | 33.17M | 40.61M | 43.28M | 36.92M | 44.81M | 52.13M | 39.38M | 16.14M | 12.68M | 12.57M | 13.89M | 9.52M | 23.61M | 19.71M | 11.34M | 10.84M | -41.41M |
| Diluted EPS | 0.27 | 0.93 | 0.74 | 1.09 | 0.56 | 1.22 | 1.24 | 0.92 | 0.36 | 1.37 | 1.19 | 0.94 | 0.42 | 1.37 | 1.44 | 0.93 | 1.03 | 1.07 | 1.30 | 1.11 | 0.95 | 1.18 | 1.54 | 1.43 | 1.74 | 1.85 | 1.59 | 1.93 | 2.26 | 1.71 | 0.70 | 0.55 | 0.55 | 0.61 | 0.42 | 1.03 | 0.86 | 0.50 | 0.47 | -1.81 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.28B | 1.43B | 1.84B | 1.80B | 1.88B | 1.93B | 1.78B | 1.77B | 1.93B | 1.99B | 1.86B | 1.87B | 2.35B | 2.77B | 2.33B | 2.18B | 2.33B |
| Gross Profit | 233.10M | 235.98M | 255.55M | 291.55M | 281.69M | 249.56M | 308.24M | 339.27M | 346.17M | 339.35M | 339.71M | 383.61M | 395.81M | 427.07M | 277.60M | 272.21M | 269.89M |
| Operating Income | 104.89M | 107.90M | 118.46M | 128.72M | 109.15M | 90.69M | 122.79M | 127.83M | 154.84M | 149.26M | 127.26M | 171.52M | 170.78M | 207.34M | 58.61M | 70.48M | 78.55M |
| Net Income | 63.05M | 65.43M | 71.98M | 79.40M | 72.83M | 57.10M | 75.97M | 86.19M | 100.77M | 111.12M | 103.13M | 126.77M | 137.80M | 147.15M | 40.20M | 50.37M | 46.90M |
| Diluted EPS | 5.84 | 2.95 | 3.21 | 3.49 | 3.18 | 2.49 | 3.32 | 3.73 | 4.31 | 4.76 | 4.42 | 5.45 | 5.92 | 6.38 | 1.75 | 2.20 | 2.05 |
| R&D Expense | - | 24.22M | 25.13M | 28.03M | 28.78M | 27.24M | 30.32M | 34.86M | 33.17M | 33.52M | 34.14M | 36.00M | 38.78M | 40.90M | 35.73M | 33.54M | 34.80M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Jun 2013 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 811.43M | 901.12M | 985.48M | - | 1.17B | 1.16B | 1.24B | 1.35B | 1.50B | 1.51B | 1.58B | 1.75B | 2.07B | 2.43B | 2.36B | 2.30B | 2.36B |
| Total Equity | 209.23M | 290.43M | 349.49M | 401.21M | 478.99M | - | 552.29M | 535.55M | 556.98M | 634.60M | 740.10M | 807.42M | 891.78M | 986.69M | 1.07B | 1.17B | 1.22B | 1.17B | 1.24B |
| Cash & Equivalents | 8.26M | 98.52M | 111.20M | 84.10M | 76.88M | - | 133.35M | 85.22M | 176.14M | 225.74M | 298.89M | 300.19M | 315.38M | 349.94M | 159.19M | 173.75M | 129.82M | 99.67M | 132.69M |
| Long Term Debt | - | - | 159.96M | 164.97M | 149.56M | 100.00M | 235.25M | 246.90M | 312.55M | 288.86M | 268.30M | 239.02M | 198.53M | 160.81M | 322.86M | 455.03M | 401.25M | 332.63M | 340.98M |
| Current Liabilities | - | - | 205.63M | 233.23M | 247.17M | - | 268.99M | 249.51M | 243.24M | 297.26M | 320.25M | 338.58M | 339.11M | 416.55M | 500.48M | 670.65M | 607.87M | 669.03M | 666.49M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 166.44M | 66.13M | 77.38M | 108.97M | 150.31M | - | - | 212.16M | 198.86M | 171.13M | 218.43M | 235.22M | 72.14M | 160.76M | 174.88M | 162.05M | 147.88M |
| Investing Cash Flow | -34.74M | -97.25M | -101.39M | -87.45M | -167.56M | - | - | -130.52M | -82.68M | -107.81M | -112.67M | -139.03M | -376.83M | -308.09M | -258.67M | -116.94M | -89.05M |
| Financing Cash Flow | -41.96M | 42.37M | -2.10M | -29.48M | 76.25M | - | - | -29.77M | -50.50M | -51.65M | -90.49M | -64.93M | 117.33M | 166.21M | 33.28M | -64.52M | -35.44M |
| Capital Expenditure | -42.63M | -73.75M | -83.17M | -83.16M | -92.86M | -101.82M | -119.35M | -103.08M | -78.61M | -86.65M | -105.57M | -125.79M | -194.48M | -301.55M | -260.33M | -122.78M | -122.51M |
| Free Cash Flow | 123.81M | -7.62M | -5.79M | 25.81M | 57.45M | - | - | 109.09M | 120.25M | 84.48M | 112.86M | 109.42M | -122.35M | -140.79M | -85.46M | 39.28M | 25.37M |
| Share Buybacks | 1.93M | 4.91M | 1.51M | 2.10M | 2.27M | 7.92M | 2.00M | 2.41M | 6.00M | 15.50M | 13.18M | 15.25M | 16.97M | 24.95M | - | - | - |
| Dividends Paid | 9.56M | 10.57M | 11.51M | 12.76M | 14.47M | 15.39M | 16.30M | 17.33M | 18.91M | 20.86M | 23.10M | 25.41M | 28.08M | 30.57M | 32.87M | 33.95M | 35.03M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 18.3% | 16.5% | 13.9% | 16.2% | 15.0% | 12.9% | 17.4% | 19.2% | 18.0% | 17.0% | 18.3% | 20.5% | 16.9% | 15.4% | 11.9% | 12.5% | 11.6% |
| Operating Margin % | 8.2% | 7.5% | 6.4% | 7.1% | 5.8% | 4.7% | 6.9% | 7.2% | 8.0% | 7.5% | 6.8% | 9.2% | 7.3% | 7.5% | 2.5% | 3.2% | 3.4% |
| Net Margin % | 4.9% | 4.6% | 3.9% | 4.4% | 3.9% | 3.0% | 4.3% | 4.9% | 5.2% | 5.6% | 5.5% | 6.8% | 5.9% | 5.3% | 1.7% | 2.3% | 2.0% |
| ROE % | 21.7% | 18.7% | 17.9% | 16.6% | 13.2% | 10.7% | 13.6% | 13.6% | 13.6% | 13.8% | 11.6% | 12.8% | 12.8% | 12.6% | 3.3% | 4.3% | 3.8% |
| ROCE % | - | 17.8% | 17.7% | 17.4% | 12.2% | 9.9% | 12.3% | 12.1% | 13.1% | 12.7% | 10.3% | 12.8% | 10.9% | 11.8% | 3.3% | 4.3% | 4.6% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 14.58% | 3.31M | $193.25M |
| 2 | HighTower Advisors, LLC | 7.00% | 1.59M | $92.80M |
| 3 | Vanguard Portfolio Management LLC | 5.98% | 1.36M | $79.31M |
| 4 | Dimensional Fund Advisors LP | 4.92% | 1.12M | $65.20M |
| 5 | Deprince, Race & Zollo, Inc. | 4.17% | 947.45K | $55.30M |
| 6 | Vanguard Capital Management LLC | 4.15% | 941.99K | $54.98M |
| 7 | State Street Corporation | 3.97% | 902.66K | $52.68M |
| 8 | American Century Companies Inc | 3.22% | 732.12K | $42.73M |
| 9 | Geode Capital Management, LLC | 2.33% | 529.56K | $30.91M |
| 10 | Charles Schwab Investment Management, Inc. | 2.04% | 464.45K | $27.11M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for SCL
(SCL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxObWEyZnh1a1dUZFNnaFQzblZMWXB6eGhKWXdPRG1RNGtYdDg5Yzg4cWI5UkxzNmZtYlNSaW5TRTNpNVgyNFJYRHJXakYtQjBlS01ZWlVaU3BRREo2b3ZOSDBVSXB1VmNBOWpCVzYzMWZiMW1LaXNrOFluU1daZ0tvS09KX0JWUWNrcmlnb3…
A Look At Stepan (SCL) Valuation After Recent Share Price Weakness - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxNUmVSNEd0UXpfTmtPQmdiYzFrOWQwTnVPNlRlVEUxendBX216RkpXRkx4YTNfckdQYThfcjZ3TUFPOTNCTHpJbXZIMXFoUDZWd0h3YXpUU25Rek5ZVktJbVVYaHU5eEtVUURqOGdEcDFFdF9pZTlPSWNnQ2UxdnhpdUxDUzZPZUI0SW1VTj…
Stepan Reports First Quarter 2026 Results - PR Newswire
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxOdXVma2E2WU83SkZVLTRzS2VQS0xheXFqaXhnb2x4Z1ItelBUbm5RT3BOVzVnOGgzZjZXWjc1eXZFN3BTU19VRmctSEZvemZLaGVHdkZqYUVUVFVkMjQ2ZW9hYlQ3VmZTTnc3eTNRWlY5aFFrQlBmYllHZTFibDkzOFcwUmZleEJ1dWpoU3…
Stepan Company's Discount Isn't Over Yet (NYSE:SCL) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxNSjU2TnlxRS15RnM3elFITW1BVGQ1al9IQ3ktRjNILVJ5aEw4bEw1TGhyX25xZEEtT2NQRTEwV1FfMWkxNXhPTFB2ODFQbkZpakNLSjBFS2ZNamp6OEVUTHhVdl9DZGIzQlg4a0V3bzByYjQ3UmtTWnRHcnVWMjVVLVpPazlsZw?oc=5" t…
Price to earnings forward of Shield Corporation Limited – PSX:SCL - TradingView
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxQMGZ5Vm1mbkhaZ2NKREdmYklMY1dZbmQ3S1lWN3pLeHd2T2RiNTJzcmpIOVA1dktnZWNZVzhVZGFwTkZCVllpU2ZKWlI2VFYyYnZaYU1LaHgyM1BmMG56ZUNSaTlqNTRfM0pvRll2dWR6VVYxYnlVZzRnSXJKVXhHTlZJUk4wS3lmNFlDVF…
Stepan lines up July 29 earnings call and results release - Stock Titan
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxPS2dRZTlEQ2pNaUdHVnFlN1p3WVFlYkY0YWJEN0VlcnhfeWFsOUdpeW9BZVpGOXFvVHNCWWZxUTRSRWc0bWprWU90YkY1M293dktCbkhDbXVkd195WGxtbUdGcXRlYVRPdFZfVEw4ZzhtU2FFX2VRLV8yUFRoUE92cEwzUkJCdUh6dGJBYj…
SCL — Frequently Asked Questions
What is the current share price of Stepan Company (SCL)?
As of 2026-07-15 16:51 PDT, Stepan Company (SCL) trades at $58.64 on NYSE. Its 52-week range is $41.31 to $66.21.
What is the market capitalisation of SCL?
Stepan Company (SCL) has a market capitalisation of $1.33B on NYSE.
What is the P/E ratio of SCL?
SCL trades at a trailing price-to-earnings (P/E) ratio of -94.58. The industry average P/E is 23.08. Its price-to-book (P/B) ratio is 1.11.
Does SCL pay a dividend?
Stepan Company (SCL) currently offers a dividend yield of 2.78%.
What is the return on equity (ROE) of SCL?
SCL has a return on equity (ROE) of -1.19%. Its return on capital employed (ROCE) is 4.64%.
Is SCL a good stock to buy?
This page provides a data-driven analysis of Stepan Company (SCL), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.